Navigation Links
Mount Sinai presents treatment trends, vaccine research, prognosis data at ASCO
Date:5/17/2012

atology and Medical Oncology at Mount Sinai, and his team will describe a new multicenter study investigating a vaccine targeting multiple myeloma, a currently incurable blood cancer. Dr. Cho's team discovered that a gene called Melanoma Antigen Gene (MAGE)-A3 is highly expressed in multiple myeloma, and when that gene is "turned off," the cancer cells die and the disease cannot proliferate. Dr. Cho and his team are investigating a vaccine based on the protein produced by the MAGE-A3 gene that triggers an immune system response intended to kill multiple myeloma cells.

Paired with an adjuvant, or a chemical that boosts immune response, and white blood cells primed with the vaccine, the MAGE-A3 vaccine is administered to patients undergoing autologous stem cell transplant. The first dose is delivered six weeks before stem cell transplant; the primed white blood cells are infused three days after the stem cell transplant and boosted by a second vaccination ten days after the transplant. Over the next 270 days, the patient receives six additional booster vaccinations.

The study plans to enroll 16 patients. If a 50 percent response to the vaccination is achieved, the research team will initiate a study in a larger patient population to further evaluate clinical efficacy.

"While currently available treatments for multiple myeloma help patients live longer and with a better quality of life, this disease remains incurable," said Dr. Cho. "Immunotherapies have enormous potential in this patient population, and we hope the MAGE-A3 protein vaccine will bring us closer to a cure."

  • New Gene Model Predicts Survival in Prostate Cancer Patients Resistant to Hormone Therapy (Abstract #4516, Tuesday, June 5, 2012, 12:00PM-12:15PM CT, E Arie Crown Theater)

    Patients with prostate cancer who do not respond to hormone therapy have varying rates of long-term survival, ranging from months to several years. To better predict s
    '/>"/>


Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Great recession reflux amounts to more hunger among seniors
2. David H. Koch donates $10 million to Mount Sinais Jaffe Food Allergy Institute
3. Mount Sinai first to use visually guided catheter ablation system to treat AFib patient
4. When the mountains call . . .
5. Small amount of exercise could protect against memory loss in elderly, CU study suggests
6. Mount Sinai researchers discover possible new target for sarcoma treatment and prevention
7. Amount of HIV in Genital Fluid Linked to Transmission
8. Mount Sinai finds promising clue to mechanism behind gene mutation that causes Parkinsons disease
9. Trace Amounts of Radiation Reach California; No Health Risk, Experts Say
10. Mount Sinai researcher finds unexpected temperature sensation for a light detector
11. Number of Mountain Bike Injuries Dropping
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... ... with a ribbon-cutting ceremony on Aug. 26, generously hosted by the Collinsville Chamber ... appointments via AdvantaClean’s National Call Center and website since Aug. 17. , The ...
(Date:8/31/2015)... ... 2015 , ... American Family Care (AFC), the nation’s leading ... in Tennessee with the opening of a new urgent care facility at 9203 ... in Tennessee, and 148th in the U.S. overall. , “We’re excited to continue ...
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito , a ... their competencies in managing challenging conversations, announced today that Glenn Albright, Ph.D., the ... of Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit taking ...
(Date:8/31/2015)... ... August 31, 2015 , ... In preparation for this November’s National Family ... BEAN™ personal sound amplifier, is offering caregivers “7 Reasons to Care about Hearing Health.” ... coping with a variety of home healthcare challenges, specifically as they relate to caring ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... for physicians and allied health professionals dedicated to using lifestyle as a ... the establishment of the Lifestyle Medicine Lifetime Achievement and Trailblazer Awards, with ...
Breaking Medicine News(10 mins):Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3
... in human cases of bird flu, causing increasing fear of ... in the scientific community to combat this impending and much ... risen since October 5 when scientists from the U.S. Army ... similarities between the bird flu strain in Asia, called H5N1, ...
... flu pandemic has created a stir worldwide with US President ... developers to speed up the process of developing a vaccine ... than 80 countries and international organizations met in Washington on ... officials including those from the World Health Organization (WHO) have ...
... Online Publication, released on the 5th of October, which ... diseases, has a comprehensive report on the threat of ... by Union Health Minister Dr Anbumani Ramadoss, the need ... challenge of chronic diseases in India was highlighted, stating ...
... Though technologic developments bring social and economic benefits ... are difficult to predict and manage. With rapid ... communications, children are increasingly exposed to EMFs at ... childhood leukemia and exposure to extremely low frequency ...
... found a new gene based test for identifying DNA fusion, ... research team is focusing on detection of genes // linked ... called as Acute Lymphoblastic Leukemia (ALL). The researchers took more ... is given by chemotherapy which kills the leukemia cells and ...
... one of life’s most distressing events, bringing in its wake ... reaction to the disease, but could have grave consequences. Because ... have an impact not only on the progression, but also ... in the ordinary course of human life, have been shown ...
Cached Medicine News:Health News:Strategies to prevent the rising tide of the epidemic of chronic diseases 2Health News:Hazards of Electromagnetic Fields for children 2Health News:Depression May Be A Risk Factor For Cancer Initiation 2
(Date:8/31/2015)... N.J. , Aug. 31, 2015  ... a late-stage biopharmaceutical company developing products that address ... oncology and biodefense, announced today it has completed ... the Data Review Committee (DRC) earlier this year, ... SGX942 is a first-in-class innate defense regulator (IDR) ...
(Date:8/31/2015)... -- Premune and Innovet today ... agreement for Redonyl ® Ultra. The product, which ... dermatology market, is a nutritional supplement based on PEA-um ... dogs and cats. Redonyl ® Ultra is currently ... been received positively in the country by veterinarians and ...
(Date:8/31/2015)... Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company ... for the treatment of diseases of the central nervous ... IND submission has passed review by the US Food ... Phase 1 clinical trial in patients with metastatic colon ... to 31 December 2015. Bionomics, CEO & ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4
... BNVI ), a pharmaceutical company focused on the ... health and cancer, today announced that Dr. Isaac Cohen, O.M.D., ... Cowen and Company 31st Annual Healthcare Conference at 9:30 a.m. ... held at the Boston Marriott Copley Place, in Boston, Massachusetts. ...
... March 7, 2011   PDL BioPharma, Inc. (PDL) ... the first quarter ending March 31, 2011 of approximately $83 ... the first quarter of 2010, an expected 34 percent year-over-year ... million settlement received from UCB Pharma S.A. (UCB) in January ...
Cached Medicine Technology:Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference 2PDL BioPharma Provides First Quarter 2011 Revenue Guidance of $83 Million 2PDL BioPharma Provides First Quarter 2011 Revenue Guidance of $83 Million 3PDL BioPharma Provides First Quarter 2011 Revenue Guidance of $83 Million 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: